Location History:
- Almere, NL (2017 - 2019)
- Hillegom, NL (2016 - 2020)
Company Filing History:
3 out of 3 
3 out of 159 
2 out of 2 Years Active: 2016-2020
Title: Petrus Johannes Simons: Innovator in Molecular Binding Technologies
Introduction
Petrus Johannes Simons is a notable inventor based in Hillegom, Netherlands. He has made significant contributions to the field of molecular binding technologies, holding a total of five patents. His work focuses on developing innovative solutions for various human diseases, particularly those related to inflammation and cancer.
Latest Patents
One of his latest patents is titled "Binding molecules that bind human complement factor C2 and uses thereof." This invention describes means and methods for creating binding molecules that specifically target human complement factor C2. These molecules exhibit properties that inhibit C2 activity, making them useful in treating inflammatory diseases, neuro-inflammatory diseases, and ischemia-reperfusion injury. Another significant patent is "Humanized anti-CD134 (OX40) antibodies and uses thereof." This invention provides antibodies that specifically bind to human CD134, which is expressed on activated T lymphocytes. These antibodies can enhance the anti-cancer functions of effector T cells while inhibiting the suppressive functions of regulatory T cells, offering promising avenues for cancer treatment.
Career Highlights
Throughout his career, Petrus has worked with reputable companies such as Biocerox Products B.V. and Janssen Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Petrus has collaborated with notable colleagues, including Louis Boon and Jinquan Luo. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Petrus Johannes Simons is a distinguished inventor whose work in molecular binding technologies has the potential to significantly impact the treatment of various human diseases. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.